Interesting podcast about Diabetica and its products

I just listened to an interesting 13 minute podcast, where the first 7 minutes are an interview with a scientist from a Northern Ireland company called Diabetica.

Diabetica signed a licensing deal with Amylin in March of 2006 for a product that is part of Diabetica research on a molecule called Glucose-dependent insulinotropic polypeptide (GIP). I don't pretend to understand the science, but it does seem like these are smart folks working on some different ways to treat diabetes.

Now I've not yet tried Symlin, which was at least co-developed by Amylin, which sounds like a most interesting treatment option. I'm going to keep my eye on what Diabetica is up to, those Irish guys are smart.

(Disclosure: I emigrated to the US about 20 years ago, but I was a teenager living in Dublin , Ireland when I was diagnosed with diabetes in 1972.)

posted by Bernard @ 9:55 PM